These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25990344)
41. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594 [TBL] [Abstract][Full Text] [Related]
42. Late renal artery stenosis after percutaneous renal denervation. Lambert T; Blessberger H; Grund M; Steinwender C J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272 [TBL] [Abstract][Full Text] [Related]
43. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension]. Mahfoud F; Böhm M Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158 [TBL] [Abstract][Full Text] [Related]
44. Differential Approaches are Much Needed for "Real World" Management of Hypertension in the Era of "Hypertension Paradox". Kario K Curr Hypertens Rev; 2018; 14(1):2-5. PubMed ID: 29943699 [No Abstract] [Full Text] [Related]
52. Renal denervation with vincristine for the treatment of resistant hypertension: further investigations are needed to implement it globally. Castro Torres Y; Katholi RE Hellenic J Cardiol; 2014; 55(6):514-5. PubMed ID: 25432205 [No Abstract] [Full Text] [Related]
53. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial. Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060 [TBL] [Abstract][Full Text] [Related]
54. European Society of Hypertension position paper on renal denervation 2018. Schmieder RE; Mahfoud F; Azizi M; Pathak A; Dimitriadis K; Kroon AA; Ott C; Scalise F; Mancia G; Tsioufis C; J Hypertens; 2018 Oct; 36(10):2042-2048. PubMed ID: 30015759 [TBL] [Abstract][Full Text] [Related]
55. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation. VonAchen P; Hamann J; Houghland T; Lesser JR; Wang Y; Caye D; Rosenthal K; Garberich RF; Daniels M; Schwartz RS Cardiovasc Revasc Med; 2016; 17(7):470-473. PubMed ID: 27493150 [TBL] [Abstract][Full Text] [Related]
56. Renal sympathetic denervation in resistant hypertension late after surgical repair for aortic coarctation. Lurz P; Daehnert I; Gutberlet M; Desch S Eur Heart J; 2013 Dec; 34(45):3500. PubMed ID: 23821399 [No Abstract] [Full Text] [Related]
57. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension. Mahfoud F; Renkin J; Sievert H; Bertog S; Ewen S; Böhm M; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Parise H; Haratani N; Pathak A; Persu A JACC Cardiovasc Interv; 2020 Feb; 13(4):471-484. PubMed ID: 32081241 [TBL] [Abstract][Full Text] [Related]
58. Renal denervation for uncontrolled hypertension: critical review of the evidence. Chen C; Upadhyay A Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849 [TBL] [Abstract][Full Text] [Related]
59. Renal sympathetic nerve denervation for the treatment of resistant hypertension. Palmer SC; Judkins C; Williams PD; Whitbourn RJ Med J Aust; 2013 Aug; 199(3):160-2. PubMed ID: 23909527 [TBL] [Abstract][Full Text] [Related]